These discrepancies could reflect the capacity of melanoma cells to activate the BRAF protein in an NRAS-independent manner as well as that these melanoma cell lines are more dependent on the MAPK/ERK activation pathway compared to colorectal cells, where the predominant pathway seems to be the PI3K/AKT pathway. This evidence concerns the gene NRAS and melanoma.